Whole Blood versus Plasma Samples—How Does the Type of Specimen Collected for Testing Affect the Monitoring of Cytomegalovirus Viremia?
Viral infections, or their reactivations, are one of the most important groups of transplantation complications that can occur among recipients of both hematopoietic cells and solid organ transplants. They are the most commonly caused by cytomegalovirus (CMV). Currently, the use of whole blood or pl...
Main Authors: | Mateusz Rzepka, Dagmara Depka, Eugenia Gospodarek-Komkowska, Tomasz Bogiel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/11/11/1384 |
Similar Items
-
Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan
by: Shu-Li Yang, et al.
Published: (2021-10-01) -
Diagnostic Value of Whole-Blood and Plasma Samples in Epstein–Barr Virus Infections
by: Mateusz Rzepka, et al.
Published: (2023-01-01) -
Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
by: Moritz B. Immohr, et al.
Published: (2021-12-01) -
Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients
by: Guy Shapira, et al.
Published: (2023-11-01) -
Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusionCentral MessagePerspective
by: Rafaela V.P. Ribeiro, MD, PhD, et al.
Published: (2023-06-01)